Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134768) titled 'Senaparib Maintenance Therapy in Patients With Platinum-Sensitive, Recurrent Ovarian Carcinoma : A Single-Arm, Single-Center Clinical Study' on Oct. 20.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Condition:
endometrioid ovarian cancer, primary peritoneal cancer, fallopian tube cancer
Recruitment Status: Recruiting
Phase: 4
Date of First Enrollment: 2025-10-27
Target Sample Size: Senaparib:20;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html...